Related Experiment Video
Updated: Jun 27, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
Conversion of a Validated Melanoma Risk Stratification Tool Into a Tablet-Based Patient Questionnaire for Targeted
Neha Gupta1, Dennis P Kim1, Alexa Conomikes1
1Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Summary
Patient self-administered melanoma risk assessment tools in primary care can effectively identify high-risk individuals for targeted screening. This approach aids in early detection and referral for melanoma.
Area of Science:
- Dermatology
- Primary Care Medicine
- Epidemiology
Background:
- Melanoma risk stratification in primary care is crucial for early detection.
- Identifying at-risk individuals facilitates timely intervention.
Purpose of the Study:
- To convert and implement a validated risk stratification tool as a patient self-administered tablet-based survey.
- To assess the effectiveness of a patient self-administered tool for melanoma risk stratification in primary care.
Main Methods:
- The Mackie risk stratification tool was adapted into a patient questionnaire.
- The survey was optimized for sensitivity and specificity in academic dermatology practices.
- The tool was administered to patients in primary care settings from 2019-2021.
- Key performance metrics including Number Needed to Screen (NNS) were calculated.
Main Results:
- Out of 7,893 respondents, 2,051 (26%) were classified as high-risk.
- The Number Needed to Screen (NNS) to identify one melanoma case was 64 within the high-risk group.
Conclusions:
- Self-administered risk stratification tools can be integrated into primary care to identify individuals needing targeted melanoma screening.
- Further research is recommended to enhance the specificity and sensitivity of these tools for specific populations.
